Hillgene Was Awarded the TOP 10 Most Promising CXO Companies of [China Biopharmaceutical Industry in 2022]

On August 4-5, the 6th Biomedical Innovation Cooperation Conference and the 2022 China Biomedical Industry Value List Awards Ceremony were held at the Kempinski Hotel Suzhou Jinji Lake. The conference lasted for 2 days and held 12 special forums, focusing on the most cutting-edge technical information and interpreting the latest industrial policies. It comprehensively linked the industry, academia, research and finance platforms in the form of keynote reports, roundtable discussions, one-on-one business docking, special invitation dinners, awards ceremonies, start-up support plans, project demand releases, poster presentations, etc.

Spectrum Bio was invited to participate in the awards ceremony and won the "Top 10 Most Promising CXO Companies" award. Mr. Richard, COO of Spectrum Bio, was invited to attend the "2022 China Biomedical Industry Value List Awards Ceremony and Invitation Dinner" held at the State Guest Hall on the 2nd floor of the Kempinski Hotel Suzhou Jinji Lake at 18:00 on the evening of August 4, 2022, and accepted the award.

This award is judged by combining multiple dimensions such as competitive factors, commercialization factors, value factors, strategic factors, product factors, and team factors, and deeply evaluates industries, industries, and enterprises to form the "2022 China Biopharmaceutical Industry Value List".

This is not only an affirmation of Spectrum Bio's past, but also a constant spur to its future development. In the future, Spectrum Bio will continue to move forward and help the development of the cell drug industry.